Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd has announced the outcome of its Board meeting held on 03rd August 2026. The Board approved the unaudited standalone financial results for the 01st quarter ended 30th June 2026, along with the Limited Review Reports. Additionally, the Board approved loan facilities of up to ₹650 Crores to subsidiaries or associates, and a loan of up to ₹25 Crores to a material subsidiary. The financial results are available on the company's website and will be published in newspapers as per SEBI regulations.

Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd. will host a conference call with analysts and investors on August 4, 2026, to discuss its business strategy and outlook post Q1FY27 financial results.

Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 03/08/2026 to consider and approve the unaudited financial results for the 1st quarter ended June 30, 2026.

Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd has received approval from both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) for the listing of 1,98,67,549 new equity shares. These shares, each with a face value of Rs. 2/-, were issued to qualified institutional buyers through a qualified institutional placement (QIP). This intimation confirms the final procedural step for the shares to be traded on the exchanges following the successful completion of the QIP.